Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
This open-label study assesses the single-dose pharmacokinetics of intravenously-administered
MNTX in healthy adult male and female subjects in the absence of, and in the presence of,
orally-administered cimetidine.
Phase:
Phase 1
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.